Contact
Please use this form to send email to PR contact of this press release:
CytoDyn’s Two-Year Update on Its PRO 140 Monotherapy Study in HIV Accepted at CROI 2017
TO:
Please use this form to send email to PR contact of this press release:
CytoDyn’s Two-Year Update on Its PRO 140 Monotherapy Study in HIV Accepted at CROI 2017
TO: